← Back to Clinical Trials
Recruiting NCT06262464
NCT06262464 An OCD Prevention Programme for at Risk Adults
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT06262464 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Babes-Bolyai University |
| Condition | Obsessive-Compulsive Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-02-09 |
| Primary Completion | 2025-07-31 |
Trial Parameters
Condition Obsessive-Compulsive Disorder
Sponsor Babes-Bolyai University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 200
Sex ALL
Min Age 18 Years
Max Age 65 Years
Start Date 2024-02-09
Completion 2025-07-31
Interventions
Prevention
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The main purpose of this randomised clinical trial is to test the efficacy of a prevention program for adult who are at risk of developing OCD, thus constituting a form of tertiary prevention.
Eligibility Criteria
Inclusion Criteria: \- age over 18 Exclusion Criteria: * clinically diagnosed OCD * current psychiatric/psychotherapeutic treatment * personality disorder diagnosis * suicidal ideation
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology